Classify the plasma lipoproteins. Describe their metabolism and the role of apolipoproteins. Add a note on the hyperlipoproteinaemias.
Definition and Structure
Lipoproteins = spherical macromolecular complexes that transport water-insoluble lipids in plasma.
- Core — non-polar lipids: triglyceride and cholesteryl ester
- Surface — amphipathic: phospholipid, free cholesterol and apolipoproteins
- Density is inversely related to lipid content — the more triglyceride, the lower the density
Classification
| Class | Chief lipid | Source | Function | Electrophoresis |
|---|---|---|---|---|
| Chylomicron | Dietary triglyceride (85%) | Intestine | Carries dietary fat to tissues | Origin |
| VLDL | Endogenous triglyceride | Liver | Carries hepatic triglyceride to tissues | Pre-β |
| IDL | TG and cholesterol | From VLDL | Transient | Broad β |
| LDL | Cholesterol (50%) | From VLDL | Delivers cholesterol TO tissues — "bad" | β |
| HDL | Protein (50%) | Liver, intestine | Reverse cholesterol transport — "good" | α |
Important Apolipoproteins
| Apo | Found on | Function |
|---|---|---|
| Apo A-I | HDL | Activates LCAT |
| Apo B-100 | VLDL, IDL, LDL | Ligand for the LDL receptor |
| Apo B-48 | Chylomicron | Chylomicron assembly |
| Apo C-II | Chylomicron, VLDL, HDL | Activates lipoprotein lipase |
| Apo E | Chylomicron remnant, VLDL, IDL | Remnant uptake by the liver |
Metabolism
A. Exogenous pathway (dietary fat)
Dietary fat → chylomicron (intestine) → Lymph → blood; acquires apo C-II and E from HDL → Lipoprotein lipase on capillary endothelium hydrolyses TG → Free fatty acids to adipose and muscle → Chylomicron remnant → taken up by liver via apo E
B. Endogenous pathway
Liver → VLDL → Lipoprotein lipase removes TG → IDL → Further TG removal by hepatic lipase → LDL → Taken up by LDL (apo B-100) receptors in liver and tissues
C. Reverse cholesterol transport
Nascent HDL from liver and intestine → Picks up free cholesterol from tissues via ABCA1 → LCAT (activated by apo A-I) esterifies it → Mature HDL → Delivers cholesterol to liver (SR-B1) or transfers to VLDL/LDL via CETP → Excreted in bile
- This is why HDL is protective — it is the only route by which peripheral cholesterol returns to the liver for excretion
Lipoprotein Lipase
- Located on the capillary endothelium of adipose tissue, muscle and lactating breast
- Activated by apo C-II; induced by insulin
- Released into plasma by heparin — "clearing factor"
- The adipose enzyme has a high Km (works after a meal); the muscle enzyme a low Km (works when fat is scarce)
Fredrickson Classification of Hyperlipoproteinaemias
| Type | Raised | Defect |
|---|---|---|
| I | Chylomicrons | Lipoprotein lipase or apo C-II deficiency |
| IIa | LDL | LDL receptor defect — familial hypercholesterolaemia |
| IIb | LDL and VLDL | Combined hyperlipidaemia |
| III | IDL | Apo E2/E2 — broad beta disease |
| IV | VLDL | Over-production; the commonest |
| V | VLDL and chylomicrons | Mixed |
LDL Receptor Pathway (brown and Goldstein)
LDL binds the LDL receptor via apo B-100 → Internalised in clathrin-coated pits → Endosome → lysosome → Cholesteryl ester hydrolysed → free cholesterol → Three consequences
- Inhibits HMG-CoA reductase → less synthesis
- Down-regulates the LDL receptor → less uptake
- Activates ACAT → excess is esterified and stored
- This feedback is absent on the macrophage scavenger receptor, which is why foam cells form
Applied Aspects
- Lipid profile — total cholesterol, triglyceride, HDL, and LDL by the Friedewald formula: LDL = Total − HDL − (TG ÷ 5). Invalid if triglyceride exceeds 400 mg/dL
- Abetalipoproteinaemia — no apo B → no chylomicrons or VLDL → fat malabsorption, acanthocytosis, retinitis pigmentosa, neurological damage from vitamin E deficiency
- Tangier disease — ABCA1 defect → almost no HDL → orange tonsils and neuropathy
- Very high triglyceride (> 1000 mg/dL) causes acute pancreatitis — a medical emergency independent of cardiovascular risk
- Lp(a) resembles plasminogen and is an independent risk factor for thrombosis and atherosclerosis
- Fasting is no longer required for a routine lipid profile in most guidelines, except when triglyceride is very high
- Familial combined hyperlipidaemia (type IIb) is the commonest genetic dyslipidaemia and a frequent finding in premature coronary disease
- Secondary causes must be excluded first — hypothyroidism, nephrotic syndrome, diabetes, alcohol, and drugs such as thiazides and steroids
All questions in Lipid Metabolism
- Q1Describe the β-oxidation of fatty acids. Explain the carnitine shuttle, the energetics for palmitate, and the regulation of the pathway. ★
- Q2Describe the synthesis and utilisation of ketone bodies. Explain the causes of ketosis and the biochemical basis of diabetic ketoacidosis. ★
- Q3Describe the de novo synthesis of fatty acids. Explain the citrate shuttle, the role of acetyl-CoA carboxylase, and compare it with β-oxidation. ★
- Q4Describe the biosynthesis and regulation of cholesterol. Give its functions, transport and fate. Add a note on hypercholesterolaemia. ★
- Q5Classify the plasma lipoproteins. Describe their metabolism and the role of apolipoproteins. Add a note on the hyperlipoproteinaemias. ★
- SN1Describe the carnitine shuttle and its regulation. ★
- SN2Define fatty liver. Describe its causes and mechanisms. Add a note on lipotropic factors. ★
- SN3Define essential fatty acids. Give their sources, functions and the features of deficiency. ★
- SN4Describe the synthesis and actions of the eicosanoids. Explain the action of aspirin. ★
- SN5Describe lipoprotein lipase with its site, activator and significance.
- SN6Classify phospholipids and describe their functions. Add a note on lung surfactant. ★
- SN7Describe the biochemical basis of atherosclerosis and the lipid risk factors. ★